Crescent Biopharma to Present at Three Investor Conferences
Crescent Biopharma will present at three investor conferences. The supplied text gives no dates beyond the start of one date, or further details.
Related stories
Coface New Business Hits Record €105M for 9M-26
Coface said new business reached a record €105 million for 9M-26.
M impact | EQUITY | Nov 02, 2026, 04:37 PM UTC
Q·CAPITAL Q3 Comprehensive Loss Widens to CHF 842,361
M impact | EQUITY | Nov 02, 2026, 04:37 PM UTC
Q·CAPITAL’s Q3 2026 Loss Widens
Q·CAPITAL reported a wider loss in the third quarter of 2026 than a year earlier.
M impact | EQUITY | Nov 02, 2026, 04:37 PM UTC
Coface Reports Net Income, Including Third-Quarter Results
Coface reported an annualized RoATE.
M impact | EQUITY | Nov 02, 2026, 04:37 PM UTC
Grifols Reports Q3 Revenue of €538 Million
M impact | EQUITY | Nov 02, 2026, 04:37 PM UTC
Motilal Oswal Recommends Buying Indostar Capital Finance, Sets Rs 240 Target
Motilal Oswal’s report says Indostar Capital Finance’s 2QFY27 PAT was INR132m, versus INR115m in 1QFY27. NII grew 34% year over year to INR2b; other income was INR407m and opex ros
M impact | EQUITY | Nov 02, 2026, 04:37 PM UTC